Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas

Cancer Genetics

Volumn 208, Issue 1-2, 2015, Pages 25-34

  Li, Xiao ^a   Hughes, Sarah C ^a   Wevrick, Rachel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cancer testis antigen; Computational biology; Individualized medicine; Melanoma antigen; Neoplasm RNA; RNA sequencing

Indexed keywords

MELANOMA ANTIGEN; PROTEOME;

ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MELANOMA ANTIGEN GENE; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; BIOLOGY; CLASSIFICATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; INFORMATION RETRIEVAL; INTERNET; KAPLAN MEIER METHOD; MALE; METABOLISM; MUTATION; NEOPLASM; PROCEDURES; PROGNOSIS;

COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFORMATION STORAGE AND RETRIEVAL; INTERNET; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA-SPECIFIC ANTIGENS; MUTATION; NEOPLASMS; PROGNOSIS; PROTEOME;

EID: 84924536829     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2014.11.005     Document Type: Article

References (39)

1. Almeida L.G., Sakabe N.J., deOliveira A.R., et al. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res 2009, 37:D816-D819.
2. Tyagi P., Mirakhur B. MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy. Clin Lung Cancer 2009, 10:371-374.
3. Coulie P.G., Van den Eynde B.J., van der Bruggen P., et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 2014, 14:135-146.
4. Barker P.A., Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. JNeurosci Res 2002, 67:705-712.
5. Sang M., Wang L., Ding C., et al. Melanoma-associated antigen genes - an update. Cancer Lett 2011, 302:85-90.
6. Doyle J.M., Gao J., Wang J., et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 2010, 39:963-974.
7. Aprelikova O., Pandolfi S., Tackett S., et al. Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. Cancer Res 2009, 69:616-624.
8. Liu W., Cheng S., Asa S.L., et al. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res 2008, 68:8104-8112.
9. Yang B., O'Herrin S.M., Wu J., et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 2007, 67:9954-9962.
10. Duan Z., Duan Y., Lamendola D.E., et al. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 2003, 9:2778-2785.
11. Palecek J., Vidot S., Feng M., et al. The Smc5-Smc6 DNA repair complex: bridging of the Smc5-Smc6 heads by the KLEISIN, Nse4, and non-Kleisin subunits. JBiol Chem 2006, 281:36952-36959.
12. Li X., Zhuo R., Tiong S., et al. The Smc5/Smc6/MAGE complex confers resistance to caffeine and genotoxic stress in Drosophila melanogaster. PLoS One 2013, 8:e59866.
13. Taylor E.M., Copsey A.C., Hudson J.J., et al. Identification of the proteins, including MAGEG1, that make up the human SMC5-6 protein complex. Mol Cell Biol 2008, 28:1197-1206.
14. Liu Y., Elf S.E., Miyata Y., et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009, 4:37-48.
15. Sasaki A., Hinck L., Watanabe K. RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins. JRecept Signal Transduct Res 2005, 25:181-198.
16. Simpson A.J., Caballero O.L., Jungbluth A., et al. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005, 5:615-625.
17. Cerami E., Gao J., Dogrusoz U., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012, 2:401-404.
18. Gao J., Aksoy B.A., Dogrusoz U., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013, 6:pl1.
19. Ley T.J., Miller C., Ding L., et al. Genomic and epigenomic landscapes of adult de novoacute myeloid leukemia. NEngl J Med 2013, 368:2059-2074. for the Cancer Genome Atlas ResearchNetwork.
20. Koboldt D.C., Fulton R.S., McLellan M.D., et al. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. for the Cancer Genome Atlas Network.
21. Getz G., Gabriel S.B., Cibulskis K., et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013, 497:67-73. for the Cancer Genome Atlas Research Network.
22. Bell D., Berchuck A., Birrer M., et al. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. for the Cancer Genome Atlas Research Network.
23. Creighton C.J., Morgan M., Gunaratne P.H., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013, 499:43-49. for the Cancer Genome Atlas Research Network.
24. De Faveri L.E., Hurst C.D., Platt F.M., et al. Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer. Br J Cancer 2013, 108:1368-1377.
25. Hakimi A.A., Ostrovnaya I., Reva B., et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clin Cancer Res 2013, 19:3259-3267.
26. Brooks S.A., Brannon A.R., Parker J.S., et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014, 66:77-84.
27. Smith H.A., McNeel D.G. The SSX family of cancer-testis antigens as target proteins for tumor therapy. Clin Dev Immunol 2010, 2010:150591.
28. Srigley J.R., Delahunt B., Eble J.N., et al. The International society of Urological Pathology (ISUP) Vancouver classification of renal Neoplasia. Am J Surg Pathol 2013, 37:1469-1489.
29. Yao J., Caballero O.L., Yung W.K., et al. Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers. Cancer Immunol Res 2014, 2:371-379.
30. Dunn G.P., Rinne M.L., Wykosky J., et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 2012, 26:756-784.
31. Colman H., Zhang L., Sulman E.P., et al. Amultigene predictor of outcome in glioblastoma. Neuro Oncol 2010, 12:49-57.
32. Wood L.D., Parsons D.W., Jones S., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
33. Laban S., Atanackovic D., Luetkens T., et al. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer. Int J Cancer 2014, 135:1142-1152.
34. Decoster L., Wauters I., Vansteenkiste J.F. Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development. Ann Oncol 2012, 23:1387-1393.
35. Kobayashi M., Taniura H., Yoshikawa K. Ectopic expression of necdin induces differentiation of mouse neuroblastoma cells. JBiol Chem 2002, 277:42128-42135.
36. Lafontaine J., Tchakarska G., Rodier F., et al. Necdin modulatesproliferative cell survival of human cells in response to radiation-induced genotoxic stress. BMC Cancer 2012, 12:234.
37. Asai T., Liu Y., Di Giandomenico S., et al. Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells. Blood 2012, 120:1601-1612.
38. Haviland R., Eschrich S., Bloom G., et al. Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer. PLoS One 2011, 6:e24923.
39. Hoek K., Rimm D.L., Williams K.R., et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004, 64:5270-5282.